×
Sera Prognostics EBIT 2021-2024 | SERA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sera Prognostics ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Sera Prognostics EBIT 2021-2024 | SERA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Sera Prognostics ebit from 2021 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$125.1B
Cencora (COR)
$45B
ICON (ICLR)
$25B
DiDi Global (DIDIY)
$19B
Avantor (AVTR)
$18.4B
Natera (NTRA)
$15.7B
Revvity (RVTY)
$15.4B
Viatris (VTRS)
$14.2B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.2B
Charles River Laboratories (CRL)
$10.6B
Sonic Healthcare (SKHHY)
$8.8B
Doximity (DOCS)
$7.4B
Bausch + Lomb (BLCO)
$7B
HealthEquity (HQY)
$6.8B
PACS (PACS)
$6.2B
Organon (OGN)
$5.1B
Life Times (LTH)
$4.9B
Sotera Health (SHC)
$4.7B
Surgery Partners (SGRY)
$4.1B
Concentras Parent (CON)
$3B
GoodRx Holdings (GDRX)
$2.8B
BrightSpring Health Services (BTSG)
$2.5B
Ardent Health Partners (ARDT)
$2.4B
Progyny (PGNY)
$2.2B
Alignment Healthcare (ALHC)
$2.2B
Premier (PINC)
$2.1B
Ryman Healthcare (RYHTY)
$1.9B
AMN Healthcare Services Inc (AMN)
$1.8B